CNMD is sharpening its focus on AirSeal, Buffalo Filter and BioBrace, betting on higher-growth platforms to drive margin gains and long-term growth.
Investors need to pay close attention to CNMD stock based on the movements in the options market lately.
CONMED Corporation (CNMD) Q1 2026 Earnings Call Transcript
| Name | Quantity | Cost | Value | Profit ($) | Gain (%) |
|---|---|---|---|---|---|
| CE Curtis Ellergodt Rothschild Investment LLC | 39 | $2,031.28 | $1,686.36 | -$344.92 | -16.98% |
| SN Stephanie Nee HARBOR CAPITAL ADVISORS Inc. | 21,756 | $1.2M | $940,294.32 | -$262,056.63 | -21.8% |
| BG Bart Gancher Intech Investment Management LLC | 7,399 | $300,399.4 | $322,226.45 | $21,827.05 | 7.27% |
Point72 Asset Management LP Point72 Asset Management LP | 134,114 | $5.43M | $5.83M | $398,091.57 | 7.33% |
| YA Yinka Akinsola Blue Trust Inc. | 6,187 | $311,461.13 | $268,794.21 | -$42,666.92 | -13.7% |
| Health Care Equipment & Supplies Industry | Healthcare Sector | Patrick J. Beyer CEO | NYSE Exchange | 207410101 CUSIP |
| US Country | 3,900 Employees | 15 Sep 2025 Last Dividend | 10 Sep 2001 Last Split | 23 Jul 1987 IPO Date |
CONMED Corporation is an influential player in the medical technology sphere, with a focus on the development, manufacturing, and global sales of surgical devices and related equipment. This company caters to a broad spectrum of surgical procedures, providing innovative solutions that aim to enhance clinical outcomes for patients around the world. Operating under various esteemed brands, including Hall, CONMED Linvatec, Concept, and Shutt, the corporation has established a strong reputation for quality and innovation since its inception in 1970. Headquartered in Largo, Florida, CONMED Corporation takes a direct approach to marketing its products, targeting hospitals, surgery centers, and other healthcare institutions while also leveraging medical specialty distributors for broader reach.